Free Trial

Enzon Pharmaceuticals (ENZN) SEC Filings & 10K Form

Enzon Pharmaceuticals logo
$0.09 +0.00 (+2.27%)
As of 08/29/2025 03:05 PM Eastern

Recent Enzon Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/23/2025
7:19 AM
Enzon Pharmaceuticals (Subject)
ICAHN CARL C (Filed by)
Form SCHEDULE 13D/A
06/23/2025
5:07 AM
Enzon Pharmaceuticals (Subject)
Form 425
06/23/2025
5:06 AM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
3:37 PM
Enzon Pharmaceuticals (Filer)
Form 8-A12G/A
04/01/2025
3:30 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:30 PM
Enzon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
3:05 PM
Enzon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:ENZN) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners